Intelligence directory
Browse A–Z
Browse LongevityNext’s research articles, interventions, clinical trials and biomarker records in one alphabetical directory.
Leading punctuation is ignored. Numbers come first; accented letters and other scripts appear under Other.
Records
107 eligible records · Page 3 of 5
- Longevity Capital in 2026: Disclosed Deals, Different Instruments, and the Limits of the EvidenceArticle
- Longevity Clinic Registries: The Minimum Evidence Needed to Interpret OutcomesArticle
- Longevity Trial Endpoints: Choosing Between Clinical Outcomes, Function and BiomarkersArticle
- Look AHEADTrial
- Marine EPA/DHA supplementsIntervention
- MASTERSTrial
- Mediterranean dietary pattern with olive oil or nutsIntervention
- MetforminIntervention
- Metformin in Longevity Study (MILES)Trial
- MMPOWER-3Trial
- Model Organisms in Longevity Research: What Transfers—and What Does NotArticle
- Monitored home-based walking with weekly coaching (LITE protocol)Intervention
- Multivitamin-mineral supplementationIntervention
- Negative Longevity Trials: How to Read a Missed Endpoint Without Losing the EvidenceArticle
- NewLimit’s Series C: What Disclosed Capital and Company Milestones Actually ShowArticle
- NICETrial
- Nicotinamide mononucleotideIntervention
- Nicotinamide ribosideIntervention
- NMN prediabetic-women trialTrial
- NR in obese insulin-resistant men / NCT02303483Trial
- Partial Reprogramming in Human Testing: Programme Milestones, Safety Questions, and Evidence GapsArticle
- PEARLTrial
- PREDIMEDTrial
- PROSPER: pravastatin in older adultsTrial